235 related articles for article (PubMed ID: 27973759)
1. An update on the implications of cyclin D1 in oral carcinogenesis.
Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA
Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759
[TBL] [Abstract][Full Text] [Related]
2. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
3. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ
Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.
Miyamoto R; Uzawa N; Nagaoka S; Hirata Y; Amagasa T
Oral Oncol; 2003 Sep; 39(6):610-8. PubMed ID: 12798405
[TBL] [Abstract][Full Text] [Related]
5. BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.
Wang X; Wang C; Yan G; Kang Y; Sun G; Wang S; Zou R; Sun H; Zeng K; Song H; Liu W; Sun N; Liu W; Zhao Y
EBioMedicine; 2020 Mar; 53():102685. PubMed ID: 32113162
[TBL] [Abstract][Full Text] [Related]
6. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
[TBL] [Abstract][Full Text] [Related]
9. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
10. Activation of STAT 5-cyclin D1 pathway in chewing tobacco mediated oral squamous cell carcinoma.
Mishra R; Das BR
Mol Biol Rep; 2005 Sep; 32(3):159-66. PubMed ID: 16172916
[TBL] [Abstract][Full Text] [Related]
11.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
12. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
14. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical proliferative pattern loss linked to cyclin D1 overexpression in adjacent non-tumour epithelium in oral squamous cell carcinoma.
Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Lenouvel D; Gil-Montoya JA; Bravo M
Arch Oral Biol; 2019 Jan; 97():12-17. PubMed ID: 30321764
[TBL] [Abstract][Full Text] [Related]
16. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
[TBL] [Abstract][Full Text] [Related]
17. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
[TBL] [Abstract][Full Text] [Related]
18. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of tumor cyclin D1 expression in oral cancer.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Bravo M; Gil-Montoya JA
Arch Oral Biol; 2019 Mar; 99():177-182. PubMed ID: 30721793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]